Arboretum Ventures
303 Detroit Street, Suite 301Ann Arbor, MI 48104
Firm Size
- Assets Under Management (AUM):$648 Million
- Number of Funds:8
- Employees:
- Firm Type:Venture Capital
- Focus Areas:
Software & Technology
Healthcare
Description
Arboretum Ventures, LLC is a venture capital firm based in Ann Arbor, Michigan. Founded in 2002, the firm primarily focuses on healthcare and life sciences industries, investing in early-stage and growth-stage companies. With over $700 million in capital under management across several funds, Arboretum Ventures supports innovative companies that are developing high-potential medical technologies and therapeutics. The firm provides not only financial resources but also strategic guidance and operational support to its portfolio companies. Arboretum Ventures aims to make a positive impact on patients' lives by backing companies that have the potential to revolutionize healthcare delivery and improve patient outcomes.Latest News
Powered by
Feb 01, 2024: Avation Medical raises $22M+ from impressive line-up of new global investors to jump-start sales of the first closed-loop wearable neuromodulation technology for bladder treatment
Avation Medical , an innovative neuromodulation and digital health company with a mission to make wearable peripheral neuromodulation accessible to patients across a variety of clinical conditions, announced more than $22 million in equity financing in its oversubscribed Series C round, led by new investors ShangBay Capital and Asahi Kasei, which included Angelini Ventures, JobsOhio Growth Capital Fund, and others. Additional investments were also provided by multiple existing investors, including Arboretum Ventures, Tonkawa, Medtronic, and Avestria Ventures. The funding in the round, which remains open, will be used for the U.S. launch of the company's Vivally System.
Jan 24, 2024: Rice Biotech Launch Pad startup Motif Neurotech closes Series A financing of $18.75 million
Rice University today announced that Motif Neurotech , a neurotechnology company developing minimally invasive bioelectronics for mental health formed through the Rice Biotech Launch Pad , closed an oversubscribed Series A financing round of $18.75 million .